2015Pacific Medical JournalRequires access

Detection of macrolide-resistance mutations in 23S rRNA gene of Mycoplasma pneumoniae using a novel real-time PCR assay

Inna A. Edelstein, Mikhail V. Edelstein, Andrey V. Romanov, S. А. Ratchina, S. B. Yatsyshina, I. V. Rakovskaja, Roman S. Kozlov

Open publisher page 0 citations

Abstract

Background. Mycoplasma pneumoniae is a widespread pathogen of the respiratory tract diseases. In recent years, the data of foreign publications indicate the appearance and spread of resistant M. pneumoniae to macrolide antibiotics, which is associated with mutations in the 23S pRNA gene, mainly in positions 2063, 2064 and 2617. Methods. Studied 146 clinical samples obtained in 2006-2013. of patients with infections of the lower respiratory tract. Primary screening was done for the presence of DNA material M. pneumonia based on polymerase chain reaction (PCR) in real time. Results. The possibility of detecting and differentiation of various mutations in positions 2063, 2064 and 2617 in the 23S pRNA gene format single sample multiplex PCR in real time with subsequent melting curve analysis of fluorescently-labeled probes. In the study of clinical samples in all cases been detected 23S pDNA sequences of M. pneumoniae “wild-type” typical for phenotype of sensitivity to macrolides. Conclusions. Detection of single nucleotide corresponding replacements allows effective predict macrolide resistance phenotype, but used for this purpose methods are laborious and expensive. At present data on the prevalence and mechanisms of macrolide resistance in strains of M. pneumoniae in Russia are absent. The present study focuses on the development and validation of a new method for the determination of mutations associated with resistance to mac-rolides in M. pneumoniae, and also its use for the analysis of clinical samples in patients with lower respiratory tract infections.

About this research paper

What this paper is about

Background. Mycoplasma pneumoniae is a widespread pathogen of the respiratory tract diseases. In recent years, the data of foreign publications indicate the appearance and spread of resistant M. pneumoniae to macrolide antibiotics, which is associated with mutations in the 23S pRNA gene, mainly in positions 2063, 2064 and 2617. Methods. Studied 146 clinical samples obtained in 2006-2013. of patients with infections of the lower respiratory tract. Primary screening was done for the presence of DNA material M. pneumonia based on polymerase chain reaction (PCR) in real time. Results. The possibility of detecting and differentiation of various mutations in positions 2063, 2064 and 2617 in the 23S pRNA gene format single sample multiplex PCR in real time with subsequent melting curve analysis of fluorescently-labeled probes. In the study of clinical samples in all cases been detected 23S pDNA sequences of M. pneumoniae “wild-type” typical for phenotype of sensitivity to macrolides. Conclusions. Detection of single nucleotide corresponding replacements allows effective predict macrolide resistance phenotype, but used for this purpose methods are laborious and expensive. At present data on the prevalence and mechanisms of macrolide resistance in strains of M. pneumoniae in Russia are absent. The present study focuses on the development and validation of a new method for the determination of mutations associated with resistance to mac-rolides in M. pneumoniae, and also its use for the analysis of clinical samples in patients with lower respiratory tract infections.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background. Mycoplasma pneumoniae is a widespread pathogen of the respiratory tract diseases. In recent years, the data of foreign publications indicate the appearance and spread of resistant M. pneumoniae to macrolide antibiotics, which is associated with mutations in the 23S pRNA gene, mainly in positions 2063, 2064 and 2617. Methods. Studied 146 clinical samples obtained in 2006-2013. of patients with infections of the lower respiratory tract. Primary screening was done for the presence of DNA material M. pneumonia based on polymerase chain reaction (PCR) in real time. Results. The possibility of detecting and differentiation of various mutations in positions 2063, 2064 and 2617 in the 23S pRNA gene format single sample multiplex PCR in real time with subsequent melting curve analysis of fluorescently-labeled probes. In the study of clinical samples in all cases been detected 23S pDNA sequences of M. pneumoniae “wild-type” typical for phenotype of sensitivity to macrolides. Conclusions. Detection of single nucleotide corresponding replacements allows effective predict macrolide resistance phenotype, but used for this purpose methods are laborious and expensive. At present data on the prevalence and mechanisms of macrolide resistance in strains of M. pneumoniae in Russia are absent. The present study focuses on the development and validation of a new method for the determination of mutations associated with resistance to mac-rolides in M. pneumoniae, and also its use for the analysis of clinical samples in patients with lower respiratory tract infections.

Key concepts: Mycoplasma pneumoniae, 23S ribosomal RNA, Multiplex polymerase chain reaction, Biology, Microbiology, Polymerase chain reaction, Macrolide Antibiotics, Virology

Related papers

Back to paper searchBrowse research topicsOriginal source
Detection of macrolide-resistance mutations in 23S rRNA gene of Mycoplasma pneumoniae using a novel real-time PCR assay — Research Paper | ScholarLens